ProfTalks
Presentations on Interview preparation, pharmaceutical guidelines and personal development.- 8:09
- 11 ай бұрын
Medgel Pharma Indore Warning Letter 20 July 2023 | Learning from USFDA Warning Letters
- 10:32
- 11 ай бұрын
Baxter Pharma Warning Letter 25 July 2023 Ahmedabad | Learning from USFDA Warning Letters
- 19:03
- 11 ай бұрын
Intas Pharma Warning Letter 28 July 2023 | Learning from USFDA Warning Letters | 2023 Warning Letter
- 5:45
- 11 ай бұрын
QR Code for Top 300 Medicines in India | Government of India Directive to Curb counterfeit drugs
- 20:52
- Жыл бұрын
USFDA Inspections: Overview | Difference between USFDA Inspection & Other Authority Inspections
- 1:04:14
- Жыл бұрын
Intas Ahmedabad 483 Observation May 2023 | Learning from 483s
- 35:40
- Жыл бұрын
IPCA Laboratories Ratlam 483 Observation June 2023 | Learning from Observations | API Facility
- 38:26
- Жыл бұрын
ICH Q12 Product Lifecycle Management
- 17:22
- Жыл бұрын
ICH Q3C Guidance for Residual Solvents | Class of Residual Solvents | PDE Values of Residual Solvent
- 25:27
- Жыл бұрын
21 CFR Part 11 | Electronic Records & Electronic Signatures | GxP Computer System requirements
- 2:19:07
- Жыл бұрын
Revised EU Annex 1- Manufacture of Sterile Products (25 Aug 2022) | Comprehensive Training Module
- 34:21
- Жыл бұрын
ICH Q3D Guidance for Elemental Impurities | Example for calculating | Permitted Daily Dose (PDE)
- 19:06
- 2 жыл бұрын
USFDA Guidance for Data Integrity | USFDA Guidelines for Pharmaceutical | Easy Explanation
- 22:21
- 2 жыл бұрын
ICH Q10 Guidance for Pharmaceutical Quality System | Guideline for Pharmaceutical Industry
- 22:36
- 2 жыл бұрын
USFDA Guidance for Pharmaceutical Quality System | USFDA Guidelines for Pharmaceuticals |
- 4:51
- 3 жыл бұрын
Пікірлер